Back
Ocular Therapeutix Quote, Financials, Valuation and Earnings
Sponsored
OCUL
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
58
OCUL
Ocular Therapeutix
Last Price:
8.98
Seasonality Move:
1.23%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.Ocular Therapeutix Price Quote
$8.98
-0.01 (-0.77%)
(Updated: September 21, 2024 at 6:36 AM ET)
Ocular Therapeutix Key Stats
Buy
58
Ocular Therapeutix (OCUL)
is a Buy
Day range:
$8.83 - $9.16
52-week range:
$2.00 - $11.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
17.41
P/B ratio:
3.71%
Volume:
2.2M
Avg. volume:
888.5K
1-year change:
164.41%
Market cap:
$1.4B
Revenue:
$58.4M
EPS:
$-1.35
How Much Does Ocular Therapeutix Make?
-
How Much Are Ocular Therapeutix's Sales Annually?
OCUL Revenues are $58.4M -
How Much Profit Does Ocular Therapeutix's Make A Year?
OCUL net income is -$80.7M
Is Ocular Therapeutix Growing As A Company?
-
What Is Ocular Therapeutix's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.08% -
What Is Ocular Therapeutix's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ocular Therapeutix Stock Price Performance
-
Did Ocular Therapeutix Stock Go Up Last Month?
Ocular Therapeutix share price went up by 1.7% last month -
Did OCUL's Share Price Rise Over The Last Year?
OCUL share price rose by 164.41% over the past 1 year
What Is Ocular Therapeutix 52-Week High & Low?
-
What Is Ocular Therapeutix’s 52-Week High Share Price?
Ocular Therapeutix has traded as high as $11.31 over the past 52 weeks -
What Is Ocular Therapeutix’s 52-Week Low Share Price?
Ocular Therapeutix has traded as low as $2.00 over the past 52 weeks
Ocular Therapeutix Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ocular Therapeutix?
-
How Much Debt Does Ocular Therapeutix Have?
Total long term debt quarterly is $67.1M -
How Much Cash Does Ocular Therapeutix Have?
Cash and short term investments quarterly total is $459.7M -
What Is Ocular Therapeutix’s Book Value Per Share?
Book value per share is 2.43
Is Ocular Therapeutix Cash Flow Positive?
-
What Is OCUL Cash Flow From Operations?
Cash flow from operations (TTM) is -$88.9M -
What Is Ocular Therapeutix’s Cash Flow From Financing?
Cash flow from financing (TTM) is $483.5M -
What Is Ocular Therapeutix’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.7M
Ocular Therapeutix Return On Invested Capital
-
Is Management Doing A Good Job?
OCUL return on invested capital is -56.45% -
What Is Ocular Therapeutix Return On Assets?
ROA measures how assets are converting to revenues and is -43.43% -
What Is OCUL Return On Equity?
ROE is a measure of profitability and is -77.93%
Ocular Therapeutix Earnings Date & Stock Price
-
What Is Ocular Therapeutix's Stock Price Today?
A single share of OCUL can be purchased today for 8.99 -
What Is Ocular Therapeutix’s Stock Symbol?
Ocular Therapeutix trades on the nasdaq under the ticker symbol: OCUL -
When Is Ocular Therapeutix’s Next Earnings Date?
The next quarterly earnings date for Ocular Therapeutix is scheduled on November 7, 2024 -
When Is OCUL's next ex-dividend date?
Ocular Therapeutix's next ex-dividend date is September 22, 2024 -
How To Buy Ocular Therapeutix Stock?
You can buy Ocular Therapeutix shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ocular Therapeutix Competitors
-
Who Are Ocular Therapeutix's Competitors?
Below is a list of companies who compete with Ocular Therapeutix or are related in some way:
Ocular Therapeutix Dividend Yield
-
What Is OCUL Dividend Yield?
Ocular Therapeutix’s dividend yield currently is 0% -
What Is Ocular Therapeutix’s Payout Ratio?
Ocular Therapeutix’s payout ratio is 0% -
When Did Ocular Therapeutix Last Pay A Dividend?
The latest dividend pay date is September 22, 2024 -
What Is Ocular Therapeutix’s Dividend Per Share?
Ocular Therapeutix pays a dividend of $0.00 per share
Ocular Therapeutix Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -21.88% |
Revenue: | 8.26% | 3.75% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 14.88 |
Upside from Last Price: | 65.46% |